We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Teladoc (TDOC) Advances While Market Declines: Some Information for Investors
Read MoreHide Full Article
In the latest market close, Teladoc (TDOC - Free Report) reached $9, with a +0.78% movement compared to the previous day. The stock's change was more than the S&P 500's daily loss of 0.76%. Meanwhile, the Dow experienced a drop of 1.14%, and the technology-dominated Nasdaq saw a decrease of 0.18%.
Shares of the telehealth services provider witnessed a loss of 35.57% over the previous month, trailing the performance of the Medical sector with its loss of 0.37% and the S&P 500's loss of 7.29%.
Market participants will be closely following the financial results of Teladoc in its upcoming release. The company is expected to report EPS of -$0.33, up 32.65% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $617.44 million, down 4.44% from the prior-year quarter.
TDOC's full-year Zacks Consensus Estimates are calling for earnings of -$0.90 per share and revenue of $2.51 billion. These results would represent year-over-year changes of +84.67% and -2.22%, respectively.
Investors might also notice recent changes to analyst estimates for Teladoc. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 8.19% higher. Teladoc is currently a Zacks Rank #3 (Hold).
The Medical Services industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 71, finds itself in the top 29% echelons of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Teladoc (TDOC) Advances While Market Declines: Some Information for Investors
In the latest market close, Teladoc (TDOC - Free Report) reached $9, with a +0.78% movement compared to the previous day. The stock's change was more than the S&P 500's daily loss of 0.76%. Meanwhile, the Dow experienced a drop of 1.14%, and the technology-dominated Nasdaq saw a decrease of 0.18%.
Shares of the telehealth services provider witnessed a loss of 35.57% over the previous month, trailing the performance of the Medical sector with its loss of 0.37% and the S&P 500's loss of 7.29%.
Market participants will be closely following the financial results of Teladoc in its upcoming release. The company is expected to report EPS of -$0.33, up 32.65% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $617.44 million, down 4.44% from the prior-year quarter.
TDOC's full-year Zacks Consensus Estimates are calling for earnings of -$0.90 per share and revenue of $2.51 billion. These results would represent year-over-year changes of +84.67% and -2.22%, respectively.
Investors might also notice recent changes to analyst estimates for Teladoc. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 8.19% higher. Teladoc is currently a Zacks Rank #3 (Hold).
The Medical Services industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 71, finds itself in the top 29% echelons of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.